Rooted in China, Creating a Global Happiness EcosystemFulfilling the Needs of One Billion Families in Health, Happiness and Wealth

Fosun (May 2019)

107-0052 S-GATE AKASAKA-SANNO 2-5-1 Akasaka Minato-Ku Tokyo, Japan Tel: +81 03 5545 1754

Largo do Chiado 8, 1249-125 Lisbon, Portugal Tel: +351 213 401 500

Tower S1, Bund Finance Center,600 Zhongshan No.2 Road(E) , Shanghai, China Tel: +86 21 2315 6666Fax: +86 21 6130 3288Post Code: 200010

31st Floor, Bei j ing Fosun International Center,No. 237 North Chaoyang Road, Chaoyang Distr ict , Bei j ing, ChinaTel: +86 10 5915 2299Fax: +86 10 5915 2174Post Code: 100020

Room 808, ICBC Tower,3 Garden Road, Central, Hong Kong Tel: +852 3228Fax: 852 2509 9028

44th Floor, 28 Liberty, New York, NY 10005, USATel: +1 646 490 9830

CONTENTS22 Fosun’s

Team

10 BusinessOverview

02 Fosun’sOverview

Creating happier lives for families worldwide

ABOUT FOSUNFosun was founded in 1992. Fosun International Limited is a family-focused multinational company that has been listed on the main board of the Hong Kong Stock Exchange (00656.HK) since 2007, with total assets over RMB638.8 billion (c.US$93.1 billion) as of December 31, 2018. With its roots in China, and through technology and innovation, Fosun's mission is to create customer-to-maker (C2M) ecosystems in health, happiness and wealth, providing high-quality products and services for families around the world. Fosun International ranks No.416 on the 2019 Forbes Global 2000 List.

F O S U N ’ S O V E R V I E W

A GLOBAL INDUSTRIAL GROUP ROOTED IN CHINA

02 - 03

2013Atlantis, Sanya

Sisram Med

28 Liberty

2016Wolverhampton Wanderers

Babytree

AHAVA

Rio Bravo

BCP

Gland Pharma

HAUCK & AUFHAUSER

2017Fosun United Health Insurance

Tsingtao Brewery

St Hubert

2018Song He Lou

Baihe Jiayuan

JEVE

The Little Gym

LANVIN

Wolford

Hello Bike

Fosun Tourism Group listed on the HKEx

Babytree Group listed on the HKEx

2010Club Med

2011Bund Finance Center

2012Pramerica Fosun Life Insurance

Peak Reinsurance

Starcastle Senior Living

2003Nanjing lron & Steel

2004Zhaojin Mining

2007Yong’an P&C Insurance

Hainan Mining

Fosun International listed on the HKEx 2015

Fosun Eurasia

Cirque du Soleil

Mybank

Privatization of Club Med

Silver Cross

Thomas Cook

AmeriTrust (formerly MIG)

Resolution Property

2014ROC Oil

Fosun Hani Securities

Star Healthcare

Luz Saúde

Tom Tailor

Fidelidade

IDERA

Studio 8

1992Founded by graduates from Fudan University with initial investment of US$4,000

1994Fosun Pharma and

Forte were established

1998Fosun Pharma listed on China’s A-shares market

2002Yuyuan

MILESTONESFosun was founded in 1992 by four graduates of Fudan University. Since its establishment, Fosun has always been adhering to its cultural values of “Self-improvement, Teamwork, Performance, and Contribution to Society”. With its mission of “Creating Happier Lives for Families Worldwide”, Fosun achieved rapid development by capitalizing on the high-growth sectors that benefit from China’s economic development and investing in the fast-growing industries in different stages.

In the course of pursuing commercial value, Fosun also actively contributes its efforts to improve the business and natural environments of China so as to support the rejuvenation of the Chinese economy and culture, thus fulfilling its social responsibility as a corporate citizen.

04 - 05

Guo GuangchangChen Qiyu

Qin Xuetang

Wang Qunbin

Xu Xiaoliang

Wang CanGong Ping

BOARD OF D IRECTORS

Wang Can aged 39, is the Executive Director, Senior Vice President and the Chief Growth Officer (CGO)

of the Company.Mr. Wang is responsible for coordinating and deploying all of Fosun’s resources and global partners to facilitate the Group’s core operating capabilities, including strategic planning, technology & innovation, enhancement of products and brands, sales and marketing and creating smart mid-offices within the C2M ecosystem of Fosun. He is also responsible for the growth of customers, revenues and enterprise value of the C2M ecosystem of Fosun. Mr. Wang joined the Group in 2012, and as at the end of the Reporting Period, he has also been a non-executive director of Fosun Pharma (listed on the Hong Kong Stock Exchange and the SSE) and FTG (listed on the Hong Kong Stock Exchange), a director of Shanghai Ganglian E-Commerce Holdings Co., Ltd. (listed on the Shenzhen Stock Exchange with stock code 300226) and various companies within the Group. He once worked as the Chief Financial Officer (CFO), the general manager of Investment Management Support Center, the co-director of Fosun Technology Innovation Center, the general manager of Investment Management Department, the deputy CFO and the general manager of Financial Planning & Analysis Department of the Group. Prior to joining the Group, Mr. Wang worked in Kingdee Software (China) Co., Ltd., PricewaterhouseCoopers Zhong Tian LLP, Standard Chartered Bank (China) Limited and Huazhu Group Limited (listed on NASDAQ with stock code HTHT, formerly known as China Lodging Group, Limited). Mr. Wang was named as “Asia’s Best CFO (Industrials) -1st” for two consecutive years (2017 and 2018) in “All-Asia Executive Team” ranking organized by the authoritative financial magazine, Institutional Investor.Mr. Wang is a non-practicing member of Chinese Institute of Certified Public Accountants (CICPA) and a member of The Association of International Accountants (AIA) and the Association of Chartered Certified Accountants (ACCA). Mr. Wang graduated from Anhui University in 1997 and received an EMBA degree from China Europe International Business School in 2014.

Gong Ping aged 43, is an Executive Director and Senior Vice President o f the Company.Mr. Gong

joined the Group in 2011 and as at the end of the Reporting Period, he has also been the CEO of Fosun Hive Holdings, the chairman of Paris Realty Fund SA (listed on the Euronext Paris with stock code PAR), the vice chairman of Yuyuan (listed on the SSE), a non-executive director of Shanghai Zendai (listed on the Hong Kong Stock Exchange), a director of Resource Property (listed on the NEEQ) and a director of various companies within the Group. As at the end of the Reporting Period, Mr. Gong has been a council member of Shanghai Association For Youth Entrepreneurship And Employment. He used to serve as a senior assistant to president of the Group and the general manager of Corporate Development Department. Prior to joining the Group, Mr. Gong worked at Pudong branch and the headquarters of Bank of Shanghai as well as the PRC headquarters of Standard Chartered Bank. Mr. Gong also served as a global strategist at the headquarters of Samsung Group in Korea, carrying out special assignments across various sectors worldwide including financial services, technology and real estate.Mr. Gong graduated from Fudan University in 1998 with a bachelor’s degree in international finance, and obtained his master’s degree in finance from Fudan University in 2005. Mr. Gong also received his master’s degree in business administration from International Institute for Management Development (IMD) in Lausanne, Switzerland in 2008.

Qin Xuetang aged 55, is an Executive Director and Senior Vice President of the Company.

Mr. Qin is also serving as a director of various overseas companies within the Group. Since joining the Group in 1995, Mr. Qin has been in charge of the legal and internal control affairs of the Company, possessing in-depth knowledge in the area of mergers and acquisitions, as well as corporate governance of listed companies. In addition, Mr. Qin oversees all matters related to the Company’s audit, compliance, risk control and information disclosure. Mr. Qin received a bachelor’s degree in law in 1985 from the Southwest University of Political Science and Law and was admitted to practice law in the PRC in 1990. Prior to joining the Group, Mr. Qin worked in the Law School of Fudan University.

Xu Xiaoliang aged 45, is an Executive Director and Co-President of the Company. Mr. Xu

joined the Group in 1998, and as at the end of the Reporting Period, he has also been the chairman of Yuyuan (listed on the SSE), a non-executive director of Zhaojin Mining Industry Co., Ltd. (listed on the Hong Kong Stock Exchange with stock code 01818), a director of Shanghai Resource Property Consultancy Co., Ltd. (listed on the NEEQ with stock code 833517, “Resource Property”), Shanghai Foyo Culture & Entertainment Co., Ltd. (listed on the NEEQ with stock code 831472) and various companies within the Group. Mr. Xu was a non-executive director of Shanghai Zendai Property Limited (listed on the Hong Kong Stock Exchange with stock code 00755, “Shanghai Zendai”). As at the end of the Reporting Period, Mr. Xu has been a deputy to the 15th Shanghai Municipal People’s Congress, the co-chairman of Real Estate Association of The Zhejiang Chamber of Commerce, Shanghai, a member of Shanghai Youth Federation and a vice chairman of China Real Estate Chamber of Commerce. Mr. Xu was awarded the “Shanghai 4 May Youth Medal”and“Shanghai Top Ten Youth Business People”. Mr. Xu graduated from the Innova Education School of Singapore with a diploma in 1995 and received a master’s degree in business administration from the East China Normal University in 2002.

Chen Qiyu aged 46, is an Executive Director and Co-President of the Company. Mr. Chen

joined the Group in 1994 and as at the end of the Reporting Period he has also been an executive director and chairman of Fosun Pharma (listed on the Hong Kong Stock Exchange and the SSE), a director of Dian Diagnostics Group Co., Ltd. (listed on the Growth Enterprise Market Board of the Shenzhen Stock Exchange with stock code 300244, resigned in February 2019), a non-executive director and vice chairman of Sinopharm (listed on the Hong Kong Stock Exchange), a non-executive director of Babytree (listed on the Hong Kong Stock Exchange), a director of Sanyuan Foods (listed on the SSE) and various companies within the Group. Mr. Chen was a director of Maxigen Biotech Inc. (listed on the Taiwan Stock Exchange with stock code 1783). As at the end of the Reporting Period, Mr. Chen has been the chairman of China Medical Pharmaceutical Material Association, a vice president of China Pharmaceutical Innovation and Research Development Association, the chairman of Shanghai BioPharmaceutical Industry Association, the vice council chairman of Shanghai Society of Genetics and a member of the 13th Shanghai Standing Committee of the Chinese People’s Political Consultative Conference. Mr. Chen was a member of the 12th Shanghai Standing Committee of the Chinese People’s Political Consultative Conference. In 2018, Mr. Chen was awarded “Shanghai Excellent Constructor of Socialism with Chinese Characteristics from Non-public Sector”and“Shanghai Outstanding Entrepreneur 2018”. Mr. Chen received a bachelor’s degree in genetics from Fudan University in 1993 and an EMBA degree from China Europe International Business School in 2005.

Guo Guangchang aged 51, is an Executive Director and Chairman of

the Company. Mr. Guo is the founder of the Group and has been a director of various companies within the Group since 1994. As at the end of the Reporting Period, he has also been a director of both Fosun Holdings and Fosun International Holdings (the direct and indirect controlling shareholders of the Company, respectively). Mr. Guo was a non-executive director of Fosun Pharma (listed on the Hong Kong Stock Exchange and the SSE) and China Minsheng Banking Corp., Ltd. (listed on the Hong Kong Stock Exchange with stock code 01988 and the SSE with stock code 600016). As at the end of the Reporting Period, Mr. Guo has been the vice chairman of The General Association of Zhejiang Entrepreneurs, chairman of The Zhejiang Chamber of Commerce, Shanghai (re-positioned as the honorary chairman of The Zhejiang Chamber of Commerce, Shanghai since January 2019), etc. Mr. Guo was a deputy to the 10th and 11th National People’s Congress of the PRC, a member of the 9th and 12th National Committee of the Chinese People’s Political Consultative Conference, etc. Mr. Guo was awarded, among others,“Lifetime Achievement Award”at the 16th CNBC Asia Business Leaders Award Ceremony, “2016/17 Nobel Laureates Series - Asian Chinese Leaders Award” by Asian College of Knowledge Management,“ Lifetime Achievement Award”at the 8th World Chinese Economic Summit in 2016, etc. Mr. Guo received a bachelor’s degree in philosophy in 1989 and a master’s degree in business administration in 1999, both from Fudan University.

aged 49, is an Executive Director and CEO of the Company. Mr. Wang

is the founder of the Group and has been a director of various companies within the Group since 1994. As at the end of the Reporting Period, he has also been a non-executive director of Sinopharm (listed on the Hong Kong Stock Exchange, resigned in March 2019) and Fosun Pharma (listed on the Hong Kong Stock Exchange and the SSE). Mr. Wang was a director of Yuyuan (listed on the SSE) and Henan Lingrui Pharmaceutical Co., Ltd. (listed on the SSE with stock code 600285). Mr. Wang was awarded“Asia Pacific Outstanding Entrepreneur Awards” by Enterprise Asia and “Best Asian Corporate Director”at the Asian Excellence Recognition Awards by Corporate Governance Asia, etc., and was named one of“China’s 50 Top-performing Corporate Leaders”by Harvard Business Review. Mr. Wang received a bachelor’s degree in genetic engineering from Fudan University in 1991.

Wang Qunbin

As at the end of the Reporting Period: As at 31 December, 2018

06 - 07

FOSUN’S GLOBAL FOOTPRINTS

St. John

28 Liberty

Studio 8

AmeriTrust

Rio Bravo

Guide

THE MEDELANCaruso

Guilin Pharmaceutical

ROC Oil

Peak Reinsurance

Fosun Hani Securities

Sisram Med

AHAVA

Gland Pharma

Delhivery

IDERA

Tomamu

Club MedSt Hubert PAREFTRIDEMLANVIN

Wolverhampton Wanderers

Thomas Cook

Resolution Property

Silver Cross

Cirque du Soleil

BCP

Fidelidade

Luz Saúde

Tom TailorH&ANAGAKoller

FFT

Fosun Eurasia

Fosun Pharma YuyuanSinopharmNanjing Iron & SteelForteBFCPramerica Fosun Life InsuranceStarcastle Senior LivingCainiaoAtlantis, Sanya Star HealthcareMybank

BabytreeIntuitive FosunFosun United Health InsuranceFosun KiteAitroxHello BikeTsingtao BreweryBaihe JiayuanJEVEBig Data Medical DevelopmentThe Little Gym

1. Diagram shows selection of Fosun portfolio companies

U.S.

Australia

Hong Kong

Israel

Italy

Brazil

Portugal

India

Japan

France

U.K.

Canada

Germany

Russia

ChineseMainland

Côte d'Ivoire

1

08 - 09

In the past 26 years, Fosun has continued to be bold yet humble, implementing its twin-drivers strategy of “Industry Operations + Industrial Investment”. Fosun has been consolidating its industrial foundation to create the C2M (customer-to-maker) global happiness ecosystems that are rooted in China.

B U S I N E S S O V E R V I E W

INDUSTRY OPERATIONS + INDU STRIAL INVESTMENT

10 - 11

GROUP F INANCIAL PERFORMANCEFosun has built its success with stability and consistency, as we continue to maintain high profit growth, we manage to continuously optimize the corporate asset and liability structure. As at December 31, 2018, net profit attributable to the owners of the parent stood at RMB13.41 billion representing a 10-year CAGR of 26%. Total revenue reached RMB109.35 billion, up 24.2% from the previous year.

A ONE-STOP FAMILY HAPPINESS SOLUTIONAs an industrial group dedicated to bringing happiness to global families, Fosun has been fostering and integrating high-quality industrial resources around three core needs of families ‒ health, happiness, and wealth across the globe, thereby gradually forming a one-stop happiness solution that covers every aspect of family life.

Net Profit RMB13.41 billion

26.0%10-year CAGR of

2

4

6

8

10

12

14

16

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 20180

Total revenue reached RMB109.35 billion

RMB Billions

Year

Earnings per share RMB1.57

2.6%

Year-on-year growth

53.7%

Total debt / Total capital

Leverage Ratio

A One-Stop Happiness Solution That Covers Every

Aspect of Family LifeNet Assets

108.53billion

RMB

12 - 13

The chart only shows some of Fosun’s industrial groups.

FOSUN PHARMA

1 ECO SYSTEM + N INDUSTRIAL GROUPSFosun’s dedication to industrial development over the years has provided the Group with a solid industrial foundation, leading to the emergence of numerous industrial groups. Each industrial group is backed by a group of global leading companies, brands and products that are widely favored by customers, forming a global happiness ecosystem with 1 ecosystem + N industrial groups.

FOCUSING ON INDUSTRIAL OPERATION TO ENHANCE PRODUCT COMPET IT IVENESS AND TO BU ILD BR AND STRENGTH

A leading healthcare group in ChinaIn 2018， revenue increased by 34.59% year-on-year to RMB 24,714 millionInvestment in R & D increased 63.92% year-on-year to RMB 2,507 million

LANVINFrance’s oldest luxury couture house that remains activeAppointed Mr. Jean-Philippe Hecquet as the global CEO in August 2018Appointed Mr. Bruno Sialelli as the creative director in January 2019Successfully held the Fall-Winter 2019 Show in Paris, France in February 2019

Wolverhampton WanderersWon English Football League Championship 2017/2018 and was promoted to the English Premier League, one of the world’s top football leagues Finished in seventh place in the Premier League 2018/19 and qualified to join the UEFA Europa League 2019/20Reached semi-final of the 2018/19 FA cup

WolfordGlobal market leader for luxurious legwear and high-quality bodywearNew concept shops have been introduced in January and February 2019 in Amsterdam and Paris respectively

HAUCK & AUFHÄUSERAs of 2018 third quarter, H & A recorded a gross income of EUR141.8 million, representing an increase of 43.2% year on yearRecorded profit before tax of EUR16.5 million, representing an increase of 71.9% over the same period in 2017

Fosun Insurance PortugalAchieved a net profit of EUR293.8 million and its market share of the Portuguese market stood at 34.7% in 2018Acquired 51% stake in La Positiva Seguros y Reaseguros S.A., a market leader of the insurance industry in Peru, marking its first foray into the market of Latin America in early 2019

BCPThe largest Portuguese listed bankIn 2018, net profit increased by 61.5% year-on-year to EUR301 millionIn June 2018, BCP and Ant Financial Services Group signed a cooperation agreement, launching “Alipay in-store” payment services to link Portuguese merchants and service providers with Chinese visitors

“Rituximab Injection” (Hanlikang®) received approval as China’s first-ever self-developed biosimilar by National Medical Products Administration in February 2019HLX02 Herceptin filed new drug application

Henlius

Atlantis Sanya

YUYUAN

As a main platform of the Group’s Happiness Ecosystem, business of Yuyuan covers jewelry and fashion, fashion landmark, culture and commerce, etc.Recorded revenue of RMB33,777 million and net profit of RMB3,021 million in 2018In February 2019, Yuyuan acquired 80% stake in International Gemological Institute, expanding its resources in global industrial chain in the fields of diamonds and jewelry

A global leading leisure-focused integrated tourism groupSuccessfully listed on the main board of the Hong Kong Stock Exchange in December 2018 (Stock code: 01992)Total revenue increased by 37.9% year-on-year to RMB16,270 million in 2018Achieved a profitability turnaround, with net profit amounted to RMB389.1 million in 2018

FOSUN TOURISM GROUP

FOSUN FASHION GROUP

Industri al Groups

G

lobal Happiness Ecosystem for Families Worldwide

Fosun FashionGroup

Fosun SportsGroup

Fosun HiveHoldings

Fosun Maternal Infant & Family

Group

Nanjing Iron andSteel Co., Ltd.

Fosun Pharma

Fosun Technology & Financial Group Fosun Infrastructure

Group

Fosun FinancialServices

Fosun Energy, Industrial and Utility

Group

YuyuanFosun Tourism

Group Officially opened in April 2018Number of customer visits reached 3.2 million in 2018

Fulfilling theNeeds of

One Billion Families

14 - 15

TWIN DRIVERS OF INDUSTRY OPER AT IONS + INDU STRIAL INVESTMENTInvestment is an important pillar of the development of Fosun. The in-depth industrial experiences accumulated over the years has enabled Fosun to discover more investment opportunities around the world and to possess industrial turnaround abilities. In the future, Fosun will further enhance its values through industrial investment and industrial operations to integrate the industrial chain of Fosun, enabling the company to create new industrial products through cross- industry collaborations to drive multiplier growth of its corporate values.

FOSTER THE INDUSTRYEnter the industry through investments or incubations

Create industrial clusters through acquisitions

Cultivate industry talents with deep knowledge

STAGE I

INTEGRATED OPERATIONFormulate long-term strategy

Performance incentives

ONE Fosun synergy platform

STAGE II

INDUSTRY LEADER

Become industry leader with scalable businessLead through technology & innovationBuild top management team

STAGE III

16 - 17

R&D and Incubation

Biopharmaceuticals“Rituximab Injection” (Hanlikang) received approval for the

country’s first-ever self-developed biosimilar for treatment of non-Hodgkin lymphoma by National Medical Products Administration in February 2019

Treats B-cell lymphoma and leukemia. Significantly enhances complete response rate of patients with relapsed/refractory lymphoma

Cellular Immune Therapy

Robotic SurgeryBuild intelligent system for medical diagnosis to reduce human errorsImproves efficiency and effectiveness of medical diagnosis

Artificial IntelligenceThe most advanced minimally invasive surgery system in the worldCommitted to research on next generation machine of diagnoses and treatment on early lung cancerSignificantly improves the outcome of surgical operations and shortens hospitalization and recovery time

TECHNOLOGY & INNOVATION + CREATIVE DESIGN SMART MID-OFFICETechnology and innovation are the driving forces of Fosun’s future development. In order to take lead in technology and innovation, Fosun continues to increase investment in technology and proprietary R&D, while grasping global investment and cooperation opportunities to have comprehensive access to new technologies, thereby mastering the leading and valuable technologies that can empower business operations.

Provide cloud computing services and smart technologies to several dozens of portfolio companies

Integrate smart technology resources within Fosun ecosystem to improve operational efficiency of the ecosystem and provide customers with one-stop family happiness solution

Data Solution

Front Office (N Industrial Groups)

1. Analyze customer needs, support and guide product iteration by using artificial intelligence and big data 2. Bring together the marketing resources of the whole group to achieve integrated marketing and precise marketing

Marketing Mid-office

1. Focus on research and development to achieve breakthroughs2. Technology empowers portfolio companies and leads the Group’s technological innovation

Technology Mid-office

Strengthen the membership program of Fosun to increase customer stickiness, convert customers into users and turn users into members

Membership Mid-officeEstablish a unified system of work logic and job scheduling for the supply chain of Fosun’s ecosystem to enhance the efficiency of the supply chain for the ONE Fosun portfolio companies

Supply chain

Human Resources Finance Strategic EmpowermentRisk Management

Smart Mid-office

Smart Mid-office

Smart Mid-OfficeProvide cloud computing services and smart technologies to several dozens of portfolio companies

Enhance management capabilities of procurement and supply chain

Fosun Cloud

OnelinkplusEnhance management capabilities of procurement and supply chain

Improve efficiency of customer management within ecosystem

Youlè + ZZKur Tech

Empower the product competitivenessArtificial

IntelligenceImprove the efficiency

of financial servicesImprove the insurance

pricing capability

Lay the foundation for customer loyalty program

Block Chain

Internet of Things

18 - 19

OUTLOOK

Globalization 2.0

Fulfilling the Needs of One Bill ion Families in HealthFocus on the needs of families in the aspects of health, happiness and wealth

Industr y Operations + Industrial InvestmentEach operation becomes a leading player in its respective industry or sectorAchieve business expansion through valuable investments in industriesActively bring mature assets to the capital markets

Leverage growth momentum and resources in both China and overseas markets

Smart Mid-officeIntegrate smart technology resources within Fosun ecosystem to improve operational efficiency of the ecosystem and provide customers with one-stop family happiness solution

C2M ModelEffectively connects customers (the C-end) and makers (the M-end)Allow products to precisely and effectively tap into customersImplement customer-oriented approach to meet the full range of needs of families

Technology & Innovation + Creative DesignActively promotes technological innovation and drives rapid development of Fosun’s industrial operations

20 - 21

Leveraging resources accumulated over the past 26 years, Fosun has built a value-creation platform for its portfolio companies.

Through this platform, Fosun helps portfolio companies in achieving value enhancement in various aspects including resource sharing, management optimization and intelligence support.

F O S U N ’ S T E A M

TALENT ‒ THE MOST VALUABLE ASSET OF FOSUN

22 - 23

“A journey of a thousand miles begins with a single step”. In the past 26 years, Fosun has continued to be bold yet humble, building its success with stability and consistency. Looking ahead, we must continue to focus on product competitiveness, brand strength and the development of Fosun’s ecosystem.

Fosun is committed to focus on building “1+N” ecosystem which refers to one ecosystem and N industrial groups, such as Fosun Pharma, Fosun Tourism Group, Yuyuan. We aim to create more good products and brands that meet the needs of one billion families around the world in terms of health, happiness and wealth, and ultimately forming a global happiness ecosystem.

24 - 25

A total of around 260 people are MDs, including 100 from overseas countries, majority are locals.

Emerging markets

Moscow

Chinese Mainland

Russia

Australia

New York

Mumbai

India

Singapore

Sydney

Hong Kong

TokyoJapan

Lisbon

Portugal

U.S.

Sao Paulo

Brazil

GermanyU.K.

FrankfurtParis

Zurich Milan

London

O R GANIZAT IONAL EVOLUT ION &TALENT DEVELOPMENT STR ATEGY

Flexible organizational structure that is able to quickly respond to customer needs and adapt to market changesProject-orientated, efficient and flexible organizational structure that focused on problem solving and value creation

Mid-offices and back-offices embedded in business; provide systematic support and promote industrial upgrade through technologies including big data and artificial intelligence

Agile Organization

Bring together the wisdom and strength of Fosuners to work together and fully participate in the globalization process of FosunFurther optimize the multi-level global partner programDesign, optimize and iterate benefits and risk-sharing mechanisms of talents from all levels: short, medium and long-term incentives, traffic light systems for operational management and post-investment management

Global Partners

GLOCAL (Global + Local) Team

Adopting global talent scheme and talent localization strategy

PartnersSustained Entrepreneurial

Status

Enter and withdraw systemfor partners

Devoted to the culture and values of Fosun

Regulation and incentive plan Share benefits and risks

Multidimensional Partnership Globalized

Requirements on Entrepreneurial Spirits and Status

Entrepreneurial state: always willing to innovate and create, study, contemplate new business model, and have energy, capability and plan to reach goals.

26 - 27

Fosun takes its employees as its most valuable assets and attaches great importance to the sustainable development and nurturing of talents. Implementing the Group’s strategy and upholding its corporate culture, Fosun encourages its employees to develop their personal skills and improve their performance, thereby enabling them to grow with the company.

To d i s c o v e r a n d c u l t i v a t e o u t s t a n d i n g entrepreneurs with a global perspective to incubate potential unicorns in the industry.

“ A single spark can start a prairie fire.” We hope to groom each and every employee of Fosun to become a dazzling star ‒ A flame as we gather, and stars as we scatter.

A COMPREHENSIVE LEARNING & DEVELOPMENT SYSTEM:FOSUN UNIVERSITY*

FOSUN: EM P HASIS ON TALENTS

Mission

To become a promoter and leader who possesses strong sense of social responsibility and entrepreneurial spirit to build a world-class corporate university with attributes of Fosun.

Vision

Culture & Values Communication Center Value Empowerment Center

Talent Development AcceleratorInnovation and Entrepreneurship Acceleration Center

Leadership developmentEmpowerment of Industry Operations & Investment Business incubators

Talent development Culture & ValuesEmpowerment of technological innovation and creative design

Strategic keyword

Key projects

* Fosun University is Fosun’s internal training department

Through a talent supply chain system by combining the recruitment of external talents and the development of internal talents, we have pooled leading talents in various industries. We care about the development of entrepreneurs and strive to establish a management team that recognizes Fosun’s corporate culture and entrepreneurship.

For more than 20 years, we've been insisting on:

Attract Deploy Develop Retain

Attracting talents through

career development

Evaluating talents through

their performance

Developing talents through

their works

Building our team through

a common cause

28 - 29

FOSUN FOR GOODSince its establishment, Fosun has been firmly upholding its value of “Self-improvement, Teamwork, Performance, and Contribution to Society” and strongly committed to corporate social responsibilities to serve the society, the people and the country.

Founded in November 2012 and with Fosun and its member companies being its major donors, Fosun Foundation is a public welfare organization that covers projects in the fields of disaster relief; poverty alleviation; culture; education, young entrepreneurs and youth employment; and other corporate social responsibility (“CSR”) causes.

Protechting Startup Acceleration Program

Received applications of 235 youth entrepreneurial projects from 33 countries in 2018Winning three international awards

Fighting against malaria in Africa

Support numerous training programs for prevention and treatment of malaria as well as provide medicines and materials neededOver 20 million patients around the world with severe malaria were benefited from treatment by injectable artesunate Artesun® of Fosun Pharma

Youth Entrepreneurship

Health

The Rural Doctors Program

Covering 12 provinces, municipalities and autonomous regions in China and 37 poverty-stricken counties Helping 4,083 health centers of administrative villagesSafeguarding 10，659 rural doctors and around two million poor familiesGathering social resources and established Rural Doctor Guardian Alliance

Poverty Alleviation

Fosun Foundation Art Center*

5 Major exhibitions

54 Public education activities

210,000+ Visitor traffic

20 Cross-brand high-end events

Culture & Art

Pramerica-Fosun Spirit of Community Awards

Introduced the biggest youth recognition program based exclusively on volunteer community service in the United States to China, connecting Chinese youth charities with the rest of the worldReceived approximately 2,800 effective applications since 2013

Education

Yayoi KusamaThe Hope of the Polka Dots Buried in Infinity Will Eternally Cover the Universe, 2019Installation view at Fosun Foundation Shanghai “Yayoi Kusama: All About Love Speaks Forever”, 2019©YAYOI KUSAMACourtesy of Ota Fine Arts, Tokyo/ Singapore/ ShanghaiImage Copyright: Fosun Foundation Shanghai

Projects supported every year 40+

Charitable donations since 2012 RMB 339million

* Numbers of 2018 As at 31 December, 2018

32 - 33

END MALARIA FOR GOODIn Africa, Fosun Pharma anti-malaria medicine Artesun®, has treated over 20 million patients with severe malaria. Collaborating with Chinese government, Fosun Pharma has sponsored more than 20 high level training sessions to the officials from over 50 African countries, and has donated 148 batches of anti-Malaria stuff to Africa, including over USD 240,000 drugs to Zambia in 2018.

此宣传册是不构成复星的信息披露或投资推荐。本宣传册内提到的公司/项目包括复星、其附属公司及其管理基金所作之投资。因此，本宣传册内提到的部分公司/项目并非复星上市体系内。投资者宜参照复星的公告及年报，以获取仅与上市公司有关的所有相关信息。

免责声明

Since 2019, Fosun has designated 15th May, the International Day of Families, as the “Fosun Family Day” and the members’ day of the enterprises from One Fosun. Targeting global families, Fosun’s vision is to raise awareness about family happiness and promote family harmony.To better serve global family customers, Fosun launched “Global Family Plan” (“F-Plan”) with well-known local and global enterprises.By sharing resources and products, jointly-built channels and launching crossover products to empower each other, F-Plan will focus on the needs of family customers and launch innovative products and services that promote happy lives of global families.

Global Family Plan

34 - 35